Regenerative Medical Technology Group Inc.
RMTG
$0.0531
$0.00316.20%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 64.62% | 56.83% | 43.31% | 50.89% | -68.14% |
| Total Depreciation and Amortization | -52.82% | -40.68% | -28.86% | 30.60% | 72.93% |
| Total Amortization of Deferred Charges | -96.42% | -66.80% | -30.50% | 5.62% | 49.16% |
| Total Other Non-Cash Items | -99.92% | -99.92% | -99.90% | -136.55% | 153,717.65% |
| Change in Net Operating Assets | -9.81% | 9.58% | 18.93% | 30.55% | 33.61% |
| Cash from Operations | -37.86% | 351.51% | 302.93% | 200.61% | 129.78% |
| Capital Expenditure | 56.04% | 64.42% | 44.11% | -164.26% | -509.13% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 56.04% | 64.42% | 44.11% | -164.26% | -509.13% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 100.00% | 100.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 466.67% | -- | -- | -1,729.27% | -1,575.98% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 263.97% | 160.87% | 156.99% | 50.84% | 13.05% |